-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
O08 - Clinical activity of vofatamab, an FGFR3 selective antibody in combination with pembrolizumab in metastatic urothelial carcinoma (mUC), updated follow up results from the int...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
14
Clinical activity of vofatamab, an FGFR3 selective antibody in combination with pembrolizumab in metastatic urothelial carcinoma (mUC), updated follow up results from the interim a...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
15